Organization (Industry)
Actavis Inc.
ClinicalTrials.gov lists Actavis Inc. as lead sponsor of 95 trials. It has 13 approved assets.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials started per year with this organization as sponsor or collaborator, 1990 onward. The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.
2026 is partial: 0 registered with a 2026 start date. The dashed outline is the pace from the 0 registered with a start date through September, planned starts included, not adjusted; not a forecast. No forecast is made for this organization: it averages 0.2 trial starts a year over the five years to September, under the 5 a year the method needs.
Logo Unknown author Unknown author, via Wikimedia Commons, Public domain. Shown to identify the organization; it may be a registered trademark.
This page covers Actavis Inc.: 95 lead-sponsored trials and 0 legal-entity registrations. Part of TEVA PHARMACEUTICAL INDUSTRIES LTD.
Related companies are recorded in the same corporate group by GLEIF, ROR or a curator but are not grouped here; they are listed below with their own counts and are not included in the figures above.
Disease areas (23)
Shown in this order: most trials first (counted at this company's own legal-entity record, not the consolidated group).
| Disease area | Trials |
|---|---|
| Keratosis, Actinic | 6 |
| Rosacea | 4 |
| Asthma | 4 |
| Acne Vulgaris | 3 |
| Lecithin Cholesterol Acyltransferase Deficiency | 2 |
Showing 5 of 23 disease areas.
Trials by start year as sponsor or collaborator (20)
Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Show the table of trials by start year as sponsor or collaborator
| Year | Trials started |
|---|---|
| 2021 | 1 |
| 2019 | 2 |
| 2018 | 2 |
| 2017 | 2 |
| 2016 | 5 |
| 2015 | 9 |
| 2014 | 4 |
| 2013 | 6 |
| 2012 | 1 |
| 2008 | 1 |
Showing 10 of 20 years.
Recruitment duration, a model prediction: none of the 95 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
Approved assets (13)
Shown in this order: max phase first.
| Drug | Trials |
|---|---|
| KADIAN (morphine sulfate extended-release) capsules | 5 |
| Avinza (morphine sulfate sustained-release) capsules | 1 |
| Azelaic Acid | 2 |
| Ingenol Mebutate | 2 |
| Imiquimod | 2 |
Showing 5 of 13 approved assets.
Sponsor delivery record (1)
Enrollment hit target: the share of this sponsor's lead-sponsored trials whose actual enrollment reached the planned enrollment. On time: the share whose actual primary completion date was no later than the planned date. Each share counts only trials where we observed an estimated figure before the actual one, and n is that number of trials. Below 5 trials the count is shown as a fraction, not a percentage.
| Enrollment | Timeline |
|---|---|
| 43% hit target (n=7) | 67% on time (n=6) |
FDA inspection record (1)
| Latest classification | Inspections |
|---|---|
| NAI | 14 |
FDA recalls (55)
Shown in this order: most recent first.
| Product | Classification | Initiated |
|---|---|---|
| Refresh Relieva PF Preservative-Free Lubricant Eye Drops 0.33 fl oz (10 mL) Sterile Distributed by: Allergan, an AbbVie company Madison, NJ 07940 UPC 3 00236 63410 0, NDC 0023-6634-10. | Class II | 2020-12-30 |
| REFRESH CONTACTS¿ Contact Lens Comfort Drops 0.4 fl oz (12 mL) Sterile | Class II | 2020-12-29 |
| Skin Medica Acne Treatment Lotion (Benzoyl Peroxide 2.5%), 2 Oz bottle, Distributed in the U.S.A. by Allergan, Irvine, CA 92612, NDC 0023-4965-02 | Class III | 2020-07-06 |
| Skin Medica Acne System, Contains: Purifying Foaming Wash (Salicylic Acid 2.0%), 5 fl oz.; Purifying Toner (Salicylic Acid 2.0%), 6 fl oz,; Acne Treatment Lotion (Benzoyl Peroxide 2.5%), 2 fl oz., Distributed in the U.S.A. by Allergan, Irvine, CA 92612, UPC 300234966005 | Class III | 2020-07-06 |
| Natrelle Saline-Filled Breast Implant, for the following Styles and sizes, Style LP, Style 68 HP, Style 68 MP, Style LP/UDI: NATRELLE Style 68LP-125 Saline Round Low 10888628000513, NATRELLE Style 68LP-150 Saline Round Low 10888628000520, NATRELLE Style 68LP-175 Saline Round Low 10888628000537, NATRELLE Style 68LP-200 Saline Round Low 10888628000544, NATRELLE Style 68LP-225 Saline Round Low 10888628000551, NATRELLE Style 68LP-250 Saline Round Low 10888628000568, NATRELLE Style 68LP-275 Saline Round Low 10888628000575, NATRELLE Style 68LP-300 Saline Round Low 10888628000582, NATRELLE Style 68LP-325 Saline Round Low 10888628000599, NATRELLE Style 68LP-350 Saline Round Low 10888628000605, NATRELLE Style 68LP-400 Saline Round Low 10888628000612, NATRELLE Style 68LP-420 Saline Round Low 10888628000629, NATRELLE Style 68LP-440 Saline Round Low 10888628000636, NATRELLE Style 68LP-480 Saline Round Low 10888628000643, NATRELLE Style 68LP-525 Saline Round Low 10888628000650, NATRELLE Style 68LP-550 Saline Round Low 10888628000667, NATRELLE Style 68LP-600 Saline Round Low 10888628000674, NATRELLE Style 68LP-640 Saline Round Low 10888628000681, NATRELLE Style 68LP-680 Saline Round Low 10888628000698, Style 68 HP/UDI: NATRELLE Style 68HP-160 Saline Round High 10888628000353, NATRELLE Style 68HP-200 Saline Round High 10888628000360, NATRELLE Style 68HP-240 Saline Round High 10888628000377, NATRELLE Style 68HP-280 Saline Round High 10888628000384, NATRELLE Style 68HP-320 Saline Round High 10888628000391, NATRELLE Style 68HP-350 Saline Round High 10888628000407, NATRELLE Style 68HP-400 Saline Round High 10888628000414, NATRELLE Style 68HP-425 Saline Round High 10888628000421, NATRELLE Style 68HP-465 Saline Round High 10888628000438, NATRELLE Style 68HP-500 Saline Round High 10888628000445, NATRELLE Style 68HP-550 Saline Round High 10888628000452, NATRELLE Style 68HP-600 Saline Round High 10888628000469, NATRELLE Style 68HP-650 Saline Round High 10888628000476, NATRELLE Style 68HP-700 Saline Round High 10888628000483, NATRELLE Style 68HP-750 Saline Round High 10888628000490, NATRELLE Style 68HP-800 Saline Round High 10888628000506, Style 68 MP/UDI: NATRELLE Style 68MP-120 Saline Round Mod 10888628000155, NATRELLE Style 68MP-150 Saline Round Mod 10888628000162, NATRELLE Style 68MP-180 Saline Round Mod 10888628000179, NATRELLE Style 68MP-210 Saline Round Mod 10888628000186, NATRELLE Style 68MP-240 Saline Round Mod 10888628000193, NATRELLE Style 68MP-270 Saline Round Mod 10888628000209, NATRELLE Style 68MP-300 Saline Round Mod 10888628000216, NATRELLE Style 68MP-330 Saline Round Mod 10888628000223, NATRELLE Style 68MP-360 Saline Round Mod 10888628000230, NATRELLE Style 68MP-390 Saline Round Mod 10888628000247, NATRELLE Style 68MP-420 Saline Round Mod 10888628000254, NATRELLE Style 68MP-450 Saline Round Mod 10888628000261, NATRELLE Style 68MP-480 Saline Round Mod 10888628000278, NATRELLE Style 68MP-510 Saline Round Mod 10888628000285, NATRELLE Style 68MP-550 Saline Round Mod 10888628000292, NATRELLE Style 68MP-600 Saline Round Mod 10888628000308, NATRELLE Style 68MP-650 Saline Round Mod 10888628000315, NATRELLE Style 68MP-700 Saline Round Mod 10888628000322, NATRELLE Style 68MP-750 Saline Round Mod 10888628000339, NATRELLE Style 68MP-800 Saline Round Mod 10888628000346, | Class III | 2019-11-06 |
Showing 5 of 55 recalls.
FDA import refusals (1)
| Refused import lines | Latest refusal |
|---|---|
| 10 | 2026-01-20 |
Manufacturing and distribution sites (3)
Shown in this order: severity rank then name.
| Facility | Location | Regulators | Member organization |
|---|---|---|---|
| Actavis LLC | Edison, US | FDA, Health Canada | |
| Actavis Ltd. | Zejtun, MT | Health Canada | Actavis Limited |
| Actavis Limited | Zejtun, MT | Health Canada | Actavis Limited |
Biomarker capability evidence (119)
Shown in this order: tier desc, then gene symbol.
| Gene | Role | Evidence |
|---|---|---|
| ALB | Trial sponsor | Named in trial inclusion criteria |
| ALB | Trial sponsor | Named in trial inclusion criteria |
| ALB | Trial sponsor | Named in trial inclusion criteria |
| ALB | Trial sponsor | Named in trial inclusion criteria |
| ALB | Trial sponsor | Named in trial inclusion criteria |
Showing 5 of 119 evidence rows.
Not on this page
Checked, with nothing recorded for this organization: companies grouped under this page, active development programs, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, climate targets, as filed, workforce and board diversity, as filed, organization relationships, and clia clinical laboratory certificates.
Counted at group level under AbbVie Inc.: journals published in, us granted patents, latest dated events, and biomarkers this organization publishes on.